PROKIDNEY CORP. - Class A Common Stock (PROK)

CUSIP: 74291D104

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Class A Common Stock
Shares outstanding
141,999,700
Total 13F shares
527,620
Share change
+527,620
Total reported value
$311,428
Price per share
$0.59
Number of holders
5
Value change
+$311,428
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 74291D104?
CUSIP 74291D104 identifies PROK - PROKIDNEY CORP. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROKIDNEY CORP. - Class A Common Stock (PROK) as of Q2 2025

As of 30 Jun 2025, PROKIDNEY CORP. - Class A Common Stock (PROK) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 527,620 shares. The largest 5 holders included MARSHALL WACE, LLP, Catalyst Funds Management Pty Ltd, EverSource Wealth Advisors, LLC, Fortitude Family Office, LLC, and SBI Securities Co., Ltd.. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.